The characterization of ERBB family mutations in Chinese biliary tract cancers.

被引：0
|
作者：
Song, Tianqiang
Zhang, Wei
Li, Huikai
Chen, Ping
Chen, Xiaoqian
Shi, Junping
Zhang, Shuirong
Yao, Ming
Wang, Kai
机构：
[1] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[2] OrigiMed, Shanghai, Peoples R China
[3] OrigiMed Inc, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15595
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The characterization of IDH1 mutations in Chinese biliary tract cancers.
    Wang, Kui
    Xie, Feng
    Hu, Mingtai
    Zheng, Yuting
    Yuan, Zhengang
    Zhang, Lei
    Xue, Hui
    Liu, Jianwei
    Yang, Zhao
    Sui, Chengjun
    Xie, Yanting
    Liu, Dan
    Shi, Junping
    Hao, Qing
    Shi, Xiaoliang
    Liu, Angen
    Zhang, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] The landscape of MET mutations in Chinese biliary tract cancers.
    Xu, Shifeng
    Rao, Wei
    Zheng, Yuanwen
    Wang, Jianping
    Hu, Weiyu
    Dong, Guilan
    Wang, Jiangong
    Ren, Guibing
    Shi, Junping
    Wang, Yafei
    Javle, Milind M.
    Yao, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Comprehensive molecular characterization of Chinese patients with biliary tract cancers.
    Liu, Daren
    Ye, Dan
    Wu, Jinhong
    Yu, Yangyang
    Zhao, Lele
    Xiao, Mingzhe
    Qi, Chuang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16153 - E16153
  • [4] Biliary tract cancers. Reply
    de Groen, PC
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09): : 663 - 664
  • [5] FOLFIRI in advanced biliary tract cancers.
    Mizrahi, Jonathan
    Gunchick, Valerie
    Mody, Kabir
    Xiao, Lianchun
    Surapaneni, Phani Keerthi
    Shroff, Rachna T.
    Sahai, Vaibhav
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [6] Membranous expressions of the ErbB family proteins in advanced biliary tract cancers
    Otsuru, Toru
    Mistunaga, Shuichi
    Watanabe, Kazuo
    Ikeda, Masafumi
    CANCER SCIENCE, 2022, 113 : 563 - 563
  • [7] Biliary tract cancers. Molecular characterization and identification of novel prognostic markers
    Goeppert, B.
    PATHOLOGE, 2017, 38 : S192 - S197
  • [8] Tumor mutation burden in biliary tract cancers with ERBB family or DNA damage repair gene mutations.
    Zhang, Yongjie
    Shen, Ningjia
    Yu, Wenlong
    Fu, Xiaohui
    Song, Jia
    Zhao, Jing
    Zhang, Yuzi
    Cai, Shangli
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Comparative mutational analysis of biliary tract cancers.
    Qiu, Zhiquan
    Ji, Jun
    Xu, Yu
    Zhu, Yan
    Gao, Chun-Fang
    Wang, Guoqiang
    Li, Chengcheng
    Cai, Shangli
    Liu, Hao
    Li, Bin
    Jiang, Xiaoqing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Different clinical characteristics in biliary tract cancers.
    Lee, MA
    Woo, IS
    Kang, JH
    Hong, YS
    Lee, KS
    Kim, DG
    Kim, SN
    Park, SY
    Kim, SY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 361S - 361S
12345